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It is a great pleasure to present the first volume of 
Nanobiomedicine (NBM). This unique open-access 
scientific journal will be available at no charge to both 
readers and authors, and aims to publish up-to-date 
expert reviews, scientific manuscripts, technology 
reports, perspectives, opinions and editorials in the 
rapidly emerging field of nanotechnology and biomedical 
research.
This feature will enable the clinical and scientific 
community to publish their latest ground-breaking 
research, up-to-date reviews, perspectives and opinions 
quickly and at the same token, readers around the globe 
will be able access them online as soon as they are 
published.  
The journal will cover a broad range of topics, and at times 
selected themes, from translational and clinical 
applications that address the challenges and advances in 
diagnostics, to the delivery of therapeutics, to the 
monitoring of human diseases both in academia and 
industry. The fields that interface with nanotechnology and 
biomedical research include, but are not limited to, 
bioengineering, biophysics, biochemistry, physiology, 
pathology, nanotechnological applications in diagnostics, 
therapeutic application, vaccines, drug discovery/delivery 
and regenerative medicine.  
As our first task, the Editors-in-Chief have and will 
actively expand our Editorial Board and develop 
collaborations/partnerships with international societies 
through the conferences, meetings and webinars we will 
be attending, including recruiting scientific experts who 
understand how discovery moves from lab to the market, 
and will look to attract contributors and participation 
from a more global audience. These experts will serve as 
the central hub of the nanotechnology and biomedical 
research community and provide us with guidance on the 
latest advances.  
Nanobiomedicine's manuscript processing and peer-
reviewing is conducted entirely online. The Editorial 
Manager facilitates the manuscript processing time, 
thereby reducing costs and allowing for a better experience 
for our authors and reviewers. We have received 
numerous positive comments on this evolving electronic 
system, and we are indebted to our publisher, InTech, for 
managing this program for us. For more information, 
please visit our new manuscript submission system at 
http://www.intechopen.com/journals/show/nanobiomedi
cine/submit-your-paper. In addition, we are  looking to 
expedite the acceptance to publishing time for our 
authors and will request informal opinions from our 
Editorial Board for borderline cases.  
Nanobiomedicine will continue to work on partnering 
with other scientific societies, and academic and 
industry leaders to develop and advance the 
nanotechnology and biomedical research field and to 
allow free access to the readers. 
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We finally would like to thank InTech Open Access 
Publisher for supporting the initiatives of this journal and 
acknowledge Nanobiomedicine's Managing Editor, Ms. 
Petra Nenadic, and her team for their continuous support, 
passion and dedication all of which helped bring this 
project to fruition. In addition, we would like to thank 
our highly-renowned and respected Associate Editors 
and Editorial Board members from all over the world, 
whose areas of expertise range from  nanofluidic systems, 
to nano-scale drug delivery, to  nanoimaging, and who 
act as both bridges and catalysts to new research in their 
respective fields of nanotechnology and biomedical 
research.
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